KIZOO Technology Capital owner Michael Greve discusses the recent scientific advancements in addressing the root causes of age-related diseases in the rejuvenation biotechnology sphere—including the work of Underdog Pharmaceuticals. As one of Kizoo’s key startups, Underdog’s goal is to deliver affordable therapeutics for the prevention of heart disease and stroke through the removal of arterial plaque.

Media Contact for Kizoo:
Frank Schueler
Managing Director
Kizoo Technology Capital
fs@kizoo.com
Media Contact for Underdog:
Mike Kope
Co-CEO
Underdog Pharmaceuticals Inc
press@cyclaritytx.com